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Purpose: Overactive bladder is especially common in the elderly, although it is not regarded as a normal part of aging. Thus, we 
investigated how aging alters the cystometric and detrusor overactivity (DO) parameters and the density of nerve growth factor 
(NGF) in awake spontaneous hypertensive rats (SHRs) of different ages.
Methods: Three age groups of 12- (n=5), 17- (n=6), and 21- (n=6) week-old SHRs (Oriental Bio Inc.) were used. A catheter was 
implanted into the bladder to record the intravesical pressure (IVP), and a balloon-fitted catheter was positioned in the abdomi-
nal cavity to record the intraabdominal pressure (IAP). Of the IVP elevations above 2 cm H2O, DO was defined as a rise in IVP 
without a simultaneous change in IAP and was counted during the filling phase. We measured the expression of NGF in the blad-
ders by enzyme-linked immunosorbent assay.
Results: Both the body and bladder weights significantly increased with age, but the normalized ratio between those was not 
changed. As for DO, none of the12-week-old rats showed DO, whereas the other groups did. DO increased sig  nificantly with age 
(P=0.0045 by Mantel-Haenszel trend test), although no significant differences were found in DO frequency or pressure between 
the 17- and 21-week-old age groups. NGF did not show any significant differences among the three groups.
Conclusions: Our results showed that SHRs begin to shows DO after a certain age, such as 12 weeks of age, and that the occur-
rence of DO has a close relationship with aging. However, NGF, which is known to be increased in the bladder wall of patients 
with overactive bladder, did not show any relationship with aging in this study.
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INTRODUCTION
Overactive bladder is a urological condition defined by urgency 
as a core symptom with or without the other symptoms related 
to voiding [1]. This urgency is known to correspond to the uro-
dynamic events of detrusor overactivity (DO), which is the ob-
servation of involuntary bladder contractions during bladder 
filling [2]. Previous reports estimated that overactive bladder af-
fects about one in six adults, and the prevalence increases with 
age, although DO is not regarded to be a normal part of aging 
[3,4]. Furthermore, it is anticipated that overactive bladder will 
become more prevalent in years to come owing to an increasing 
aging population.
  The treatment goal for overactive bladder is to control the 
debilitating symptoms in order to improve the patient’s quality 
of life, which is more difficult and complex in aging people [5]. 
Anticholinergic agents are still the primary treatment of choice; 
these agents reduce the overcontractility of the detrusor muscle 
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by targeting the muscarinic receptors in the bladder [6]. How-
ever, the use of antimuscarinic drugs is limited by adverse effects 
such as dry mouth and constipation. Furthermore, age-related 
changes superimposed on the changes caused by overactive 
bladder in the lower urinary tract may make the treatment more 
complex [2]. Thus, we should clarify the effects of the aging 
process on overactive bladder more clearly, and appropriate an-
imal models are an essential adjunct in trying to address the 
considerable clinical challenges of this human condition. Spon-
taneous hypertensive rats (SHRs) are considered a useful tool 
for studying the pathogenesis of overactive bladder [7] and, fur-
thermore, are a suitable animal model for the study of overac-
tive bladder with aging because of being a genetic model. The 
hyperactive voiding in SHRs is known to be associated with el-
evated bladder nerve growth factor (NGF) secretion and related 
neuroplasticity [8,9]. 
  In the present study, we investigated when DO develops and 
how aging alters the cystometric and DO parameters in awake 
SHRs of 12, 17, and 21 weeks of age. We also observed the den-
sity of NGF in their bladders.
MATERIALS AND METHODS
Animals
Eighteen female SHRs were obtained at the age of 8 weeks from 
Orient Bio Inc. (Seongnam, Korea). They were reared in our lab-
oratory under controlled conditions with 12 hours of light and 
12 hours of darkness and were allowed free access to standard 
food pellets and tap water. They were subdivided into three age-
matched categories of 12, 17, and 21 weeks old, resulting in six 
animals in each age category. All experimental animals and pro-
cedures were performed in accordance with the Guide for the 
Care and Use of Laboratory Animals of the National Institutes 
of Health and were approved by the local animal ethics com-
mittee. One rat of 12 weeks of age died before the cystometry. 
Surgical Procedures
Three days before cystometry, catheter implantations for intra-
vesical pressure (IVP) and intraabdominal pressure (IAP) re-
cording were performed as described previously [10]. The rats 
were anaesthetized with ketamine (75 mg/kg intraperitoneally; 
Ketamine, Yuhan, Seoul, Korea) and xylazine (15 mg/kg intra-
peritoneally; Rompun, Bayer Korea Ltd, Seoul, Korea). In brief, 
the bladder was identified through a lower midline incision. A 
polyethylene catheter (PE-50; Becton Dickinson, Parsippany, 
NJ, USA) with a cuff was inserted into the bladder dome. To re-
cord IAP, a balloon (Latex, Dawoo Medical, Incheon, Korea) 
around the cuff of a catheter tip was placed 1 cm proximal to 
the bladder along the catheter to the bladder. The catheters were 
tunneled subcutaneously and exited through the skin at the 
back of the animal. The free ends of the catheters were sealed. 
In Vivo Cystometric Investigations and Evaluation
Cystometrograms were obtained in unanesthetized, unrestrained 
rats in metabolic cages. Before the cystometry, body weight was 
recorded. The indwelling catheter to the bladder was connected 
to a two-way valve that was connected via a T-tube to a pressure 
transducer (Research Grade Blood Pressure Transducer, Har-
vard Apparatus, Holliston, MA, USA) and a microinjection 
pump (PHD22/2000 pump, Harvard Apparatus). Another in-
dwelling catheter connected to an air-free abdominal balloon 
was connected to another pressure transducer to record the 
IAP. This balloon functions best when it is filled and stabilized 
to around 50 to 100 cm H2O of IAP. To prevent IAP decay by 
minute leakages through the multiple joints of the lines and 
connectors, Parafilm M laboratory sealing film (American Na-
tional Can, Chicago, IL, USA) was wrapped around the joints. 
Micturition volumes were recorded by means of a fluid collec-
tor connected to a force-displacement transducer (Research 
Grade Isometric Transducer, Harvard Apparatus). Room-tem-
perature saline was infused into the bladder continuously at a 
rate of 10 mL.h
-1. IVP, IAP, and micturition volumes were re-
corded continuously with Acq Knowledge 3.8.1 software and 
an MP150 data acquisition system (Biopac Systems Inc., Goleta, 
CA, USA) at a sampling rate of 100 Hz. The mean values from 
three reproducible micturition cycles were used for evaluation. 
IAP was defined as the recorded balloon pressure corrected by 
subtracting the lowest balloon pressure in each voiding cycle, 
which is comparable to zeroing in human cystometry. Detrusor 
pressure was defined as IVP minus IAP. The IVP rises during 
the filling phase were defined as increments of IVP that exceed-
ed 2 cm H2O from baseline, which was interpreted as abdomi-
nal straining if occurring with simultaneous similar changes in 
IAP, or as DO if occurring without simultaneous similar chang-
es in IAP. 
  The following two kinds of cystometric parameters were in-
vestigated.
  Pressure- and volume-related parameters: Basal pressure (BP; 
the lowest bladder pressure during filling), threshold pressure 
(TP; bladder pressure immediately before micturition), maxi-194    www.einj.or.kr
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mum pressure (MP; maximum bladder pressure during the 
micturition cycle), micturition volume (MV; volume of expelled 
urine), residual volume (RV; remaining urine after voiding), 
bladder capacity (BC; MV+RV), and micturition interval (MI; 
intervals between micturition contractions).
  DO-related parameters during the filling phase: Time of filling 
phase (interval from the initiation of infusion through the tube 
and the point immediately before the initiation of micturition), 
frequency of abdominal straining per minute, frequency of DO 
per minute, and increased amplitude from base to peak of DO 
spike as IVP. These frequencies were calculated on the basis of 
the time of filling phase. After cystometry, the animals were 
sacrificed by cervical dislocation. The bladder and urethra were 
removed en bloc and separated at the level of the bladder neck 
and the bladder was weighed. 
Enzyme-Linked Immunosorbent Assay (ELISA) 
Samples were homogenized with homogenization buffer (150 
mM sodium chloride, 1% triton X-100, 1% sodium deoxycho-
late, 0.1% sodium dodecyl sulfate, 50 mM Tris-HCl, pH7.5, and 
ethylenediaminetetraacetic acid), phosphatase inhibitor cocktail 
(PhosSTOP, Roche, Mannheim, Germany), and protease inhib-
itor cocktail (Sigma-Aldrich Co., St. Louis, MO, USA). The 
samples were centrifuged at 10,000 g for 4 minutes. Protein 
concentrations were determined by using the Pierce BCA Pro-
tein Assay kit (Pierce Chemical Co., Rockford, IL, USA). The 
samples were stored in a deep freezer at -80°C until assayed. 
The samples were assayed by Abfrontier’s rat NGF ELISA kit 
(Cat No.LF-EK50293). Rat NGF-specific monoclonal antibod-
ies were precoated onto 96-well plates. The rat specific detection 
polyclonal antibodies were biotinylated. The samples and bioti-
nylated detection antibodies were added to the wells subsequent-
ly and then followed by washing with phosphate-buffered sa-
line. Avidin-biotin-peroxidase complex was added and unbound 
conjugates were washed away with phosphate-buffered saline. 
HRP-substrated TMB was used to visualize HRP enzymatic re-
action. TMB was catalyzed by HRP to produce a blue color 
product that changed into yellow after adding acidic stop solu-
tion. Plates were read at 450 nM on an Elx800 microplate read-
er (Bio-Tek Instruments Inc., Winooski, VT, USA). All tissue 
NGF values were standardized by tissue protein levels and ex-
pressed in pg/mg protein.
Statistical Analyses
The results are expressed as mean values±standard errors of the 
mean. Normal distributions were confirmed by the Shapiro-
Wilks’ W test. Statistical analyses were undertaken with unpaired 
Student’s t-tests or a one-way analysis of variance with the Tukey 
post-hoc test for multiple comparisons. The data for DO inci-
dence were expressed as percentages of animals showing DO. 
Trends in percentage were tested by using a Mantel-Haenszel 
chi-squared test. All analyses were performed with GraphPad 
Prism, version 5.03, 2009 (GraphPad Software Inc., La Jolla, CA, 
USA). P<0.05 was considered statistically significant.
RESULTS
Body and Bladder Weights
The body weight of the SHRs increased with age from 12 to 21 
weeks. The bladder weight showed a pattern similar to the results 
for body weight. When bladder weight was normalized to body 
weight, however, there were no significant differences among 
Fig. 1. Effects of age on bladder (A) and body weights (g) (B) and the normalized ratio of bladder weight (mg) to body weight (g) (C) 
in spontaneous hypertensive rats (SHRs). Vertical bars represent mean results plus or minus standard error of the mean. 12 W, 











































A B Cwww.einj.or.kr    195
  Hu, et al.  •  Development and Aging of DO in SHR
http://dx.doi.org/10.5213/inj.2011.15.4.192
INJ
the three groups of 12-, 17-, and 21-week-old SHRs (Fig. 1). 
Cystometric Pressure, Volume, and DO-Related Parameters
Representative cystometric tracings from SHRs of 12, 17, and 
21 weeks of age are shown in Fig. 2. All the curves for micturi-
tion cycles with IAP measurements were reproducibly recorded 
in all animals, and the comparisons of all pressure parameters 
were performed on the basis of detrusor pressure, which is de-
rived by the differences between IVP and IAP. 
  The BPs of the SHRs decreased with age from 12 to 21 weeks. 
The TPs and MPs showed no significant differences among the 
three age groups (Fig. 3). Volume parameters of SHRs includ-
ing BC, MV, and MI showed increased values at 21 weeks of 
age compared with 12 and 17 weeks of age, but no significant 
differences were observed between the 12- and 17-week-old age 
groups. There were no RVs in any age group (Fig. 4). 
  The time of the filling phase showed increased values only in 
the 21-week-old age group (data not shown), similar to the data 
for BC, MV, and MI. The frequency of abdominal straining was 
higher in the 12-week-old age group than in the 17- and 21- 
week-old age groups (Fig. 5A). 
  DO proved by IAP was not shown in the 12-week-old age 
group, but was shown in the 17- and 21-week-old age groups. 
The incidence of DO was higher in rats in the 21-week-old age 
group (5 of 6 rats, 83.3%) than in the 17-week-old age group (3 
of 6 rats, 50.0%). Thus, in these female SHRs, DO increased sig-
nificantly with age (P=0.0045 by Mantel-Haenszel trend test) 
(Fig. 5B). However, there were no significant differences in DO 
frequency or pressure between the 17- and 21-week-old age 
groups (Fig. 5C, D).
NGF Levels in the Three Age Groups of SHRs
Subsequent evaluation by ELISA of NGF protein in bladder was 







































Fig. 2. Representative cystometric tracings in conscious spontaneous hypertensive rats (SHRs). (A) 12-week-old SHRs. (B) 17-week-
old SHRs. (C) 21-week-old SHRs. Pves, intravesical pressure; Pabd, intraabdominal pressure; Vol, volume. 
Fig. 3. Effects of age on pressure-related parameters including basal pressure (A), threshold pressure (B), and maximal pressure (C). 
Bars represent mean results plus or minus standard error of the mean. 12 W, 12-week-old SHRs; 17 W, 17-week-old SHRs; 21 W, 
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There were no significant differences among the three age 
groups, although the 21-week-old age group (1.91±1.35 pg/mg) 
showed a tendency for increased values compared with the 
12-week-old age group (1.45±0.21 pg/mg) and the 17-week-
old age group (1.36±0.18 pg/mg) (Fig. 6). 
DISCUSSION 
Our study showed that DO objectively proved by IAP came into 
existence after 12 and before 17 weeks of age in our strain of 
SHRs, thus showing a greater prevalence with increasing age. 
Therefore, this study provides direct proof of the close relation-
ship between overactive bladder and aging in the animal model 
of SHRs. However, the age at which SHRs begin to show DO 
may differ in other strains of SHRs, because of the diverse bio-
logical characteristics that result from different breeding tech-
niques and environments in different laboratories. In contrast 
with our findings for DO, NGF, which is known to be increased 
Fig. 4. Effects of age on volume-related parameters including bladder capacity (A), voiding volume (B), residual volume (C), and mic-
turition interval (D). Bars represent mean results plus or minus standard error of the mean. 12 W, 12-week-old SHRs; 17 W, 17-week-
old SHRs; 21 W, 21-week-old SHRs; NS, not significant. 
a)P<0.01. 
















































Fig. 5. Effects of age on detrusor overactivity (DO)-related parameters including abdominal straining (A), incidence of DO (B), DO 
frequency (C), and DO pressure (D). Bars represent mean results plus or minus standard error of the mean. 12 W, 12-week-old SHRs; 
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Fig. 6. Effects of age on nerve growth (pg/mg) in the bladders of 
spontaneous hypertensive rats. Bars represent mean results plus 
or minus standard error of the mean. 12 W, 12-week-old SHRs; 
17 W, 17-week-old SHRs; 21 W, 21-week-old SHRs; NS, not sig-
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  The SHR model is currently regarded as a valuable animal 
model for exploring the pathogenesis of overactive bladder 
[7,9]. The rats were originally developed as a genetic model of 
hypertension from Wistar rats and their Wistar-Kyoto inbred 
non-hypertensive controls [10]. In the course of establishing in-
bred strains of this rat model, some substrains showed a variety 
of characteristics such as the incidence of stroke, hyperactive 
behaviors, impulsivity, and hyperactive voiding [11,12], which 
have been selected as relevant rat models to mimic various hu-
man diseases, such as stroke, attention deficiency hyperactive 
disorder (ADHD), and overactive bladder. However, although 
most of the information related to these features could be gath-
ered from adult SHRs, it is important to verify the age at which 
those features start to be replicated and the changes that occur 
afterwards in SHRs. Hypertension is known to develop at about 
4 to 10 weeks of age without any artificial intervention [13]. SHRs 
are also used as an ADHD model, because the hyperactive be-
havior comes into existence at about 3 to 4 weeks of age before 
the hypertensive condition [14]. However, no studies have been 
carried out on which age of the rat is appropriate to use as a 
model of overactive bladder. Our results showed that DO was 
shown in the SHRs from the age of 17 weeks. This suggests that 
DO develops during the adolescent period, because 6 months 
of age in the rat corresponds to 18 years of human age [15]. Af-
ter that, the rats showed an increasing incidence of DO with 
age, which is applicable to the correlations of aging with the in-
cidence of overactive bladder in humans. We suggest that the 
overactive bladder research in this substrain of SHRs should be 
done from at least 12 weeks of age.
  Many research reports on the bladder have used awake cys-
tometry rather than anesthetic cystometry as a research tool, 
because the bladder is controlled by the complex physiology of 
central nervous system superimposed on the autonomic ner-
vous system [16,17]. In cystometry, the elevations of IVP, which 
is measured through a catheter in the bladder, can reflect detru-
sor contractions or abdominal straining. If no discriminations 
between those by IAP are performed for alterations in IVP, ab-
dominal straining by innate hyperactive behaviors could limit 
the usefulness of SHRs as a DO model. We reported previously 
that confirmed DO by our method for IAP measurement rep-
resented up to 76% of the pressure elevations, among total IVP 
elevations more than 2 cm H2O during the filling phase, where-
as the remaining 24% were caused by abdominal straining in 
SHRs [10]. Our results are based on this accurate methodology 
for DO. Furthermore, the observed abdominal straining in our 
animals showed a decrease with aging, which suggests that the 
rats become less active with age. 
  Our study showed that from 12 to 21 weeks of age, the blad-
ders of SHRs exhibited serial changes in bladder and body 
weights and pressure and volume parameters. The bladder and 
body weights of the SHRs increased from 12 to 21 weeks of age, 
but when bladder weight was normalized to body weight, there 
were no significant differences among the three groups of 12-, 
17-, and 21-week-old SHRs. This suggests that the bladder grows 
isometrically with the body. BP, which represents the basal ten-
sion of the bladder, decreased with aging, accompanied by in-
creased BC. In contrast, the incidence of DO during the filling 
phase increased with age, which is direct evidence that overac-
tive bladder increases with age. DO can have myogenic or neu-
rogenic etiologies, which include detrusor muscle instability 
and damage to neuronal pathways [18,19]. In SHRs, overpro-
duction of NGF in bladder tissue from SHRs was demonstrated 
and the intriguing possibility has been suggested that this leads 
to hyperinnervation of NGF-dependent sympathetic or sensory 
nerves in the bladder, resulting in hyperactive voiding in SHRs 
[8]. However, we did not observe increasing NGF in our mod-
els with age, whereas the incidence of DO did increase. The de-
tailed pathophysiological mechanisms related to NGF in the 
aging bladder should be elucidated further in future studies. 
  In conclusion, our results suggest that the DO in SHRs be-
gins to occur after a certain age, such as 12 weeks of age in our 
study. That age may be different in other strains of SHRs, be-
cause of the diverse biological characteristics that result from 
different breeding techniques in different laboratories. Howev-
er, we should remember this point when planning to use SHRs 
as a DO animal model. Because of the close relationship with 
aging, SHRs will be a good model that will enhance our under-
standing of the relationship between overactive bladder and ag-
ing.
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